Italy Acne Therapeutics Market Analysis Report 2022 to 2030

Italy Acne Therapeutics Market Analysis

$ 3999

The Italy acne therapeutics market is projected to grow from $241 Mn in 2022 to $390 Mn in 2030 with a CAGR of 6.2% for the year 2022-2030. The rise in disposable incomes in Italy and growing skincare concerns are the major factors driving the expansion of the market. The Italy acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Farmabios SpA, AmypoPharma, and Allergan are some of the key players in the market.

ID: IN10ITPH027 CATEGORY: Pharmaceuticals GEOGRAPHY: Italy AUTHOR: Parul Choudhary

Buy Now

Italy Acne Therapeutics Market Executive Analysis

The Italy acne therapeutics market size is at around $241 Mn in 2022 and is projected to reach $390 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period. The National Health System (NHS) expenses that the State pays to are set annually by the Finance Act of Italy at a general level of resources. The National Health Fund (NHF), which will increase from $128.73 Bn to $130.84 Bn in 2022, to $132.95 Bn in 2023, and to $135.06 Bn in 2024, has received an extra $2.11 Bn over the course of the next three years due to the 2022 Finance Act. Furthermore, the budget set aside for the acquisition of novel medications will rise by $105.52 Mn in 2022, $211.04 Mn in 2023, and $316.56 Mn in 2024.

Expanding vaccination coverage, restructuring hospital care and raising standards, revising the benefits package, and putting in place performance tracking systems for the health system are recent policy initiatives undertaken in Italy. Addressing historical underinvestment in the health workforce, updating outdated infrastructure and technology, and improving information infrastructure are key challenges for the health system. The Italian government intends to strengthen primary and community care by investing in facilities, enhancing the National Health Service (SSN) digital infrastructure, upgrading medical equipment, and funding health worker training with the help of its EU-funded National Recovery and Resilience Plan.

Acne vulgaris is a common skin condition that has a significant negative effect on the quality of life. Although it is not a fatal or disabling condition, it can be extremely painful and disfiguring, cause severe physiological distress, and place a substantial financial burden. Increases in anxiety, sadness, and suicidal thoughts are all linked to acne. According to a group of researchers headed by Dr. Luigi Naldi from the Study Center of the Italian Group for Epidemiologic Research in Dermatology in Bergamo, Italy, over 80% of teenagers experience breakouts of acne, but the majority of them see improvement in their skin after the age of 20. Depending on how severe it is, both topical and systemic therapies for acne are sometimes recommended in Italy. A retinol derivative known as isotretinoin has been used extensively to treat severe cases of acne and cases where other therapies have failed. Combination treatments, which typically combine benzoyl peroxide, retinoids, and/or antibiotics, are applied in cases of serious acne.

italy acne therapeutics market analysis

Market Dynamics

Market Growth Drivers

Italy is one of many countries in the world where acne is a widespread skin problem. The demand for acne therapeutics in Italy is anticipated to increase as acne becomes more common. The Italy acne therapeutics market is anticipated to increase as the general population's disposable income rises because patients may be inclined to spend money on expensive treatments. The demand for acne therapeutics is anticipated to increase as skincare and attractiveness become more important in Italy.

Market Restraints

The adverse effects of acne treatments, such as skin irritation, dryness, and redness, may prevent patients from using them. The use of alternative therapies by patients, such as over-the-counter medicines, natural therapies, or household remedies, may reduce the demand in Italy's acne therapeutics market.

Competitive Landscape

Key Players

Omikron Italia (ITA)
Farmaka (ITA)
COC Farmaceutici (ITA)
Farmabios SpA (ITA)
AmypoPharma (ITA)
Allergan
Botanix
Galderna
Bausch Health
GlaxoSmithKline
Valeant

Healthcare Policies and Regulatory Landscape

The governmental organization in charge of drug regulation in Italy since 2004 is the Italian Medicines Agency (Agenzia Italiana del Farmaco, or AIFA). Under the guidance of the Ministry of Health and under the close supervision of the Ministries of Health and Economy, the AIFA is a public organization that operates in accordance with the principles of autonomy, transparency, and efficiency. It assures the availability of medications, their safe and effective use as a tool for health protection, and the national coherence of the pharmaceutical system in accordance with the regions. It also ensures that pharmaceutical spending is governed in a manner that promotes the pharmaceutical sector's viability and compatibility with economic and financial factors. AIFA is especially concerned about the problem of counterfeit medicines. As the head of two Council of Europe (CoE) - EDQM Committees (CD-P-P and CMED), the AIFA Counterfeit Prevention Unit oversees numerous foreign projects.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Italy Acne Therapeutics Market Segmentation

By Treatment (Revenue, USD Billion):

Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents
- Anti-Inflammatory
- Other Agents
- Other Treatments

By Route of Administration (Revenue, USD Billion):

Oral
Topical
Injectable

By Age Group (Revenue, USD Billion):

10 to 17
18 to 44
45 to 64
65 and above

By Distribution Channel (Revenue, USD Billion):

Hospital Pharmacies
Retail and Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.